Plasmatic markers of haemostatic system activation in patients with solid neoplasms.
Sagripanti
A
A
Haematology Service Unit, University Hospital, Pisa, Italy.
Carpi
A
A
Ferdeghini
M
M
Baicchi
U
U
Grassi
B
B
D000990:Antithrombin III / Q000032:analysis; D001778:Blood Coagulation Disorders / Q000097:blood*; D005338:Fibrin Fibrinogen Degradation Products / Q000032:analysis; D005344:Fibrinopeptide A / Q000032:analysis; D006487:Hemostasis; D006801:Humans; D009369:Neoplasms / Q000097:blood*; D010447:Peptide Hydrolases / Q000032:analysis; D010978:Platelet Factor 4 / Q000032:analysis; D001620:beta-Thromboglobulin / Q000032:analysis
D005338:Fibrin Fibrinogen Degradation Products; C046193:antithrombin III-protease complex; D001620:beta-Thromboglobulin; C036309:fibrin fragment D; D005344:Fibrinopeptide A; D010978:Platelet Factor 4; D000990:Antithrombin III; D010447:Peptide Hydrolases